Business Overview: LanzaTech Global, Inc. (NASDAQ: LNZA)

---

Executive Summary

LanzaTech Global, Inc. is a carbon management and gas fermentation technology company headquartered in Skokie, Illinois. Originally founded in New Zealand in 2005, LanzaTech became a Nasdaq-listed company in February 2023 through a merger with special-purpose acquisition company AMCI Acquisition Corp. The company's core technology converts industrial waste gases and other carbon-rich feedstocks into ethanol and other chemical building blocks using a proprietary biocatalyst, rather than through traditional petroleum refining or crop-based fermentation.

LanzaTech matters because it is one of the few companies with a commercially proven, licensable gas fermentation platform: it reports six operating commercial plants (in China, India, and Belgium) that have collectively produced more than 139 million gallons of fuel-grade ethanol from waste gas. Full-year 2025 revenue was $55.8 million, up from $49.6 million in 2024, but the company carries a large accumulated deficit and has flagged substantial doubt about its ability to continue as a going concern, making it a high-technology, early-commercialization story rather than a mature, de-risked industrial business.

---

1. Core Business Model & How They Work

LanzaTech does not primarily build and operate its own factories. Instead, it licenses its biological and engineering technology to industrial partners who build and run the plants, and LanzaTech earns recurring, asset-light revenue from royalties, biocatalyst (microbe) supply, software, and engineering services. It also co-invests as a minority partner in a smaller number of projects and sells its own branded CarbonSmart ethanol-derived products.

[ Waste Gas / Carbon Feedstock Capture ] ⮞ [ Gas Conditioning ] ⮞ [ Gas Fermentation
  (steel/refinery off-gas, gasified        (impurity removal,       using proprietary
   biomass or MSW, landfill gas,            pressure/temp setup)     C. autoethanogenum
   reformed CO2 + H2)                                                 biocatalyst)
         ⮞ [ Ethanol + Protein Output ] ⮞ [ Downstream Conversion ] ⮞ [ Revenue ]
                                             (SAF, diesel, ethylene,    (royalties, microbe
                                              PET precursors,           & supply sales,
                                              CarbonSmart products)     engineering fees,
                                                                        equipment packages)

Key Operational Drivers

1. Licensing-First Model: Industrial partners (steel mills, refineries, waste-to-fuel developers) build and own the fermentation plant; LanzaTech earns royalties plus recurring biocatalyst/software revenue over the plant's life.
2. Minority Co-Investment: On select strategic projects, LanzaTech takes a minority equity stake rather than licensing alone, sharing in project economics. Its largest such position is in LanzaJet (a sustainable aviation fuel joint venture), in which LanzaTech held roughly 53.2% at year-end 2025, diluted to about 45.6% fully diluted after a February 2026 Series A financing round.
3. Strategic Industrial Partnerships: Named partners and collaborators include Mitsui, the Shougang joint venture in China (~9.3% LanzaTech stake, operated via a VIE structure), Brookfield (financing/framework agreement), Sekisui, ArcelorMittal, BASF, and IndianOil.
4. Customer Concentration: The single largest customer represented 37% of 2025 revenue, up from 25% in 2024, underscoring the business's current reliance on a small number of large industrial relationships while commercial scale-up continues.

---

2. Product Portfolio

---

3. Competitive Landscape

LanzaTech operates in the broader carbon-to-fuels/chemicals and sustainable-aviation-fuel space, competing against both other advanced conversion technology developers and incumbent producers with far greater financial resources.

• Gas-to-fuel / alcohol-to-jet technology peers: Topsoe, Velocys, and other advanced-conversion technology licensors compete for the same industrial partners and government grant dollars.
• Alternative low-carbon fuel producers: Gevo (isobutanol-to-jet) and Infinium (e-fuels/power-to-liquid) target overlapping SAF and renewable fuel markets with different feedstock approaches.
• Scaled incumbent SAF/renewable fuel players: Neste and World Energy already produce SAF and renewable diesel at meaningful commercial volumes, giving them a scale and capital advantage LanzaTech does not yet have.
• LanzaJet is technically a majority-owned LanzaTech affiliate rather than a true competitor, but its own fundraising and plant commissioning (e.g., the Freedom Pines Fuels facility in Georgia) are central to how the market values LanzaTech's broader platform.

LanzaTech's differentiation claim is that no single competitor currently offers an integrated combination of biocatalyst IP, plant engineering, and commercial operating experience across multiple feedstocks (steel off-gas, municipal solid waste, landfill gas) at the scale LanzaTech has already demonstrated.

---

4. Strategic Strengths & Risks

Strengths (Moat Sources)

• Proprietary biocatalyst and process IP: The C. autoethanogenum platform and related process engineering represent genuine, hard-to-replicate biological and chemical engineering know-how built over nearly two decades.
• Deep strategic industrial partnerships: Relationships with major industrials (ArcelorMittal, BASF, Mitsui, Brookfield) and government bodies (DOE, EU Innovation Fund, which awarded a €40 million grant) provide both capital and credibility.
• Proven commercial-scale operation: Six operating plants with 139+ million gallons of cumulative ethanol production is a real commercialization track record that most advanced-fuels competitors cannot point to.

Risks

• Going concern doubt: Management has explicitly stated there is substantial doubt about the company's ability to continue as a going concern, with 2025 year-end cash of only $13.2–$17.1 million against a $1.02 billion accumulated deficit and $64.9 million of operating cash outflow.
• Customer concentration: 37% of 2025 revenue from a single customer creates significant single-counterparty risk.
• China/VIE political exposure: The Shougang joint venture's variable interest entity structure in China carries regulatory and geopolitical risk.
• Dilution and capital structure: Recent financings (January 2026 private placement, February 2026 Series A round) and PIPE warrants create ongoing dilution risk for existing shareholders.
• Internal controls: The company has disclosed material weaknesses in internal control over financial reporting.
• Nasdaq listing compliance: Continued-listing requirements add pressure given the depressed share price typical of going-concern-flagged companies.

---

5. Financial Overview

---

6. Summary Conclusion

LanzaTech sits at an unusual intersection of genuine technological differentiation and acute financial fragility. Its gas fermentation platform and biocatalyst IP are real, commercially proven at six plants worldwide, and backed by blue-chip industrial partners — a combination that smaller, pre-commercial carbon-tech peers cannot match. At the same time, the company's going-concern disclosure, reliance on a single large customer for over a third of revenue, and dependence on dilutive outside financing mean the investment case hinges almost entirely on whether LanzaTech and its LanzaJet affiliate can convert technology leadership into sustainably funded, scaled commercial operations before its cash runway and partner patience run out.